Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Neoplasms

Explore clinical trials studying Respiratory Tract Neoplasms. Study availability and eligibility vary by location and protocol.

8,077 public trials 1,842 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Neoplasms trial results

Active, Not Recruiting

A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors

NCT06607185

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)

NCT06074588

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Hematology/Oncology - Santa Monica ( Site 0023) Los Angeles, California, United States
  • Mayo Clinic in Florida-Mayo Clinic Comprehensive Cancer Center ( Site 0001) Jacksonville, Florida, United States
  • Mid Florida Hematology and Oncology Center ( Site 0005) Orange City, Florida, United States
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 0003) Marietta, Georgia, United States
View all 194 locations
View Trial Details
Active, Not Recruiting

To Evaluate the Efficacy/Safety of Osimertinib Prior to CRT and Maintenance of it With Stage III, Unresectable NSCLC With EGFR Mutations

NCT06194448

Conditions
Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Beijing, China
  • Research Site Changsha, China
View all 39 locations
View Trial Details
Active, Not Recruiting

Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN)

NCT03043872

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Rogers, Arkansas, United States
  • Research Site Santa Monica, California, United States
View all 207 locations
View Trial Details

Related conditions